Authors
1 Department of Clinical Pharmacy and Pharmacy Practice, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Clinical Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract
Pyelonephritis is an inflammatory process, and oxidative stress plays a major role in it. Anti-inflammatory or antioxidant therapy given concomitantly with antibiotics should lower the risk of postpyelonephritic scarring. As the lack of review studies in the use of antioxidants in urinary tract infections was detected, this study was designed. We conducted a review of available articles in PubMed and Google Scholar with a simple review, using keywords of "antioxidant" and "pyelonephritis" with all their possible synonyms and combinations. Only interventional studies were collected. There were neither limitations on time, nor the location of the study, type of subjects, administration rout of the antioxidant drug, and the antioxidant drug used. After studying the abstracts or in some cases the full text of articles, they were categorized based on the type of antioxidant, type and number of subjects, rout of administration, dosing, duration of treatment, year of publication of the paper, and the results. A total of 66 articles published from 1991 to 2015 were found by studying just the title of the papers. Studying the abstracts reduced this number to 51 studies. Antioxidants used for this condition were Vitamins A, E, and C, cytoflavin, caffeic acid phenethyl ester, ebselen, allopurinol, melatonin, N-acetylcysteine, oleuropein, montelukast, oxytocin, ozon, dapsone, pentoxifyllin, tadalafil, bilirubin, cranberry, meloxicam, L-carnitine, colchicine, perfluoran, methylprednisolone, and dexamethasone. Studies show that antioxidants are capable of reducing oxidative stress and can be used effectively along with antibiotics to reduce the scar formation.
Keywords
with kidney disease. Pediatr Nephrol 2005;20:1599‑604.
2. Plotnikov EY, Morosanova MA, Pevzner IB, Zorova LD,
Manskikh VN, Pulkova NV, et al. Protective effect of
mitochondria‑targeted antioxidants in an acute bacterial
infection. Proc Natl Acad Sci U S A 2013;110:E3100‑8.
3. Gupta R, Verma I, Sharma S, Ganguly NK. Prevention
of tissue injury in an ascending mouse model of chronic
pyelonephritis – Role of free radical scavengers. Comp
Immunol Microbiol Infect Dis 2004;27:225‑34.
4. Mittal R, Sharma S, Chhibber S, Harjai K. Contribution
of free radicals to Pseudomonas aeruginosa induced acute
pyelonephritis. Microb Pathog 2008;45:323‑30.
5. Bychkovskikh VA, Dolgushin II, Korobeinikova ÉN. The
comparative study of indicators of immunity and state
of pro‑ and antioxidant systems in patients with chronic
pyelonephritis of single kidney in active and latent stages of
disease. Klin Lab Diagn 2012;5:43‑6.
6. Nevéus T. Can postpyelonephritic renal scarring be prevented?
Pediatr Nephrol 2013;28:187‑90.
7. DaliraniR, Yousefi ZoshkM, SharifianM, MohkamM, KarimiA,
FahimzadA, et al. Role of Vitamin A in preventing renal scarring
after acute pyelonephritis. Iran J Kidney Dis 2011;5:320‑3.
8. Ayazi P, Moshiri SA, Mahyar A, Moradi M. The effect of
Vitamin A on renal damage following acute pyelonephritis
in children. Eur J Pediatr 2011;170:347‑50.
9. Sobouti B, Hooman N, Movahed M. The effect of Vitamin E
or Vitamin A on the prevention of renal scarring in children
with acute pyelonephritis. Pediatr Nephrol 2013;28:277-83.
10. Sadeghi Z, Kajbafzadeh AM, Tajik P, Monajemzadeh M,
Payabvash S, ElmiA. Vitamin E administration at the onset of
fever prevents renal scarring in acute pyelonephritis. Pediatr
Nephrol 2008;23:1503‑10.
11. Emamghorashi F, Owji SM, Motamedifar M. Evaluation of
effectiveness of Vitamins C and E on prevention of renal scar
due to pyelonephritis in rat. Adv Urol 2011;2011:489496.
12. Yousefichaijan P, Kahbazi M, Rasti S, Rafeie M, Sharafkhah M.
Vitamin E as adjuvant treatment for urinary tract infection in
girls with acute pyelonephritis. Iran J Kidney Dis 2015;9:97‑104.
13. Gordiushina IV, Savchenko RP, Sukhanov DS, Petrov AI,
Romantsov MG. Antioxidant and membranoprotector
treatment of chronic pyelonephritis. Eksp Klin Farmakol
2011;74:27‑30.
14. Celik S, Gorur S, Aslantas O, Erdogan S, Ocak S, Hakverdi S.
Caffeic acid phenethyl ester suppresses oxidative stress
in Escherichia coli‑induced pyelonephritis in rats. Mol Cell
Biochem 2007;297:131‑8.
15. Imamoglu M, Cay A, Cobanoglu U, Bahat E, Karahan C,
Tosun I, et al. Effects of melatonin on suppression of renal
scarring in experimental model of pyelonephritis. Urology
2006;67:1315‑9.
16. Han CH, Kim SH, Kang SH, Shin OR, Lee HK, Kim HJ, et al.
Protective effects of cranberries on infection‑induced oxidative
renal damage in a rabbit model of vesico‑ureteric reflux. BJU
Int 2007;100:1172‑5.
17. Ucar F, Taslipinar MY, Alp BF, Aydin I, Aydin FN, Agilli M,
et al. The effects of N‑acetylcysteine and ozone therapy on
oxidative stress and inflammation in acetaminophen‑induced
nephrotoxicity model. Ren Fail 2013;35:640‑7.
18. Talasaz AH, Salamzadeh J, Khalili H, Eshraghi AH,
Bahremand M. Evaluating the effect of intracoronary
N‑acetylcysteine on myocardial reperfusion markers
following primary percutaneous coronary intervention in
patients with STEMI. Eur Heart J 2013;34 Suppl 1:610.
19. Csontos C, Rezman B, Foldi V, Bogar L, Drenkovics L, Röth E,
et al. Effect of N‑acetylcysteine treatment on oxidative stress
and inflammation after severe burn. Burns 2012;38:428‑37.
20. AshworthA, Webb ST. Does the prophylactic administration of
N‑acetylcysteine prevent acute kidney injury following cardiac
surgery? Interact Cardiovasc Thorac Surg 2010;11:303‑8.
21. Millea PJ. N‑acetylcysteine: Multiple clinical applications. Am
Fam Physician 2009;80:265‑9.
22. Giamarellos‑Bourboulis EJ, Geladopoulos T, Chrisofos M,
Koutoukas P, Vassiliadis J, Alexandrou I, et al. Oleuropein:
A novel immunomodulator conferring prolonged survival
in experimental sepsis by Pseudomonas aeruginosa. Shock
2006;26:410‑6.
23. Tugtepe H, Sener G, Cetinel S, Velioglu‑Ogünç A, Yegen BC.
Oxidative renal damage in pyelonephritic rats is ameliorated
by montelukast, a selective leukotriene CysLT1 receptor
antagonist. Eur J Pharmacol 2007;557:69‑75.
24. Biyikli NK, Tugtepe H, Sener G, Velioglu‑Ogünç A, Cetinel S,
Allameh and Salamzadeh: Antioxidants in urinary tract infection
Journal of Research in Pharmacy Practice / Apr-Jun 2016 / Vol 5 / Issue 2 85
Midillioglu S, et al. Oxytocin alleviates oxidative renal injury
in pyelonephritic rats via a neutrophil‑dependent mechanism.
Peptides 2006;27:2249‑57.
25. Caliskan B, Guven A, Ozler M, Cayci T, Ozcan A, Bedir O,
et al. Ozone therapy prevents renal inflammation and fibrosis
in a rat model of acute pyelonephritis. Scand J Clin Lab Invest
2011;71:473‑80.
26. Yagmurlu A, Boleken ME, Ertoy D, Ozsan M, Gokcora IH,
Dindar H. Preventive effect of pentoxifylline on renal scarring
in rat model of pyelonephritis. Urology 2003;61:1037‑41.
27. Zhu CY, Liu M, Liu YZ, Li W, Zhai W, Che JP, et al.
Preventive effect of phosphodiesterase 5 inhibitor tadalafil on
experimental post‑pyelonephritic renal injury in rats. J Surg
Res 2014;186:253‑61.
28. Kasap B, Soylu A, Ertoy Baydar D, Kiray M, Tugyan K,
Kavukçu S. Protective effects of bilirubin in an experimental
rat model of pyelonephritis. Urology 2012;80:1389.e17‑22.
29. Gurocak S, Ure I, Cumaoglu A, Gonul II, Sen I, Tan O, et al.
Renal tissue damage after experimental pyelonephritis: Role
of antioxidants and selective cyclooxygenase‑2 inhibitors.
Urology 2010;76:508.e1‑5.
30. Ushakova ND. Antiischemic efficacy of perfluoroorganic
compounds in patients with renal inflammation. Urologiia
2004;3:14‑8.
31. Huang YY, Chen MJ, Chiu NT, Chou HH, Lin KY,
Chiou YY. Adjunctive oral methylprednisolone in pediatric
acute pyelonephritis alleviates renal scarring. Pediatrics
2011;128:e496‑504.
32. Sharifian M, Anvaripour N, Karimi A, Fahimzad A,
Mohkam M, Dalirani R, et al. The role of dexamethasone
on decreasing urinary cytokines in children with acute
pyelonephritis. Pediatr Nephrol 2008;23:1511‑6
)